Controversial Avastin Spit and Ship Study to Help Triple Negative Breast Cancer Patients

BCS_Blog_DTOP_BelowTitle_336x280

EmaxHealth Health News

By Timothy Boyer for eMaxHealth.com

Undeterred by the U.S. Food and Drug Administration (FDA) removal of Avastin for breast cancer, makers of the drug are now seeking breast cancer patients who have previously used Avastin to provide saliva samples in a spit and ship study titled “The InVite Study” to determine if there is a subset of women with breast cancer—such as those diagnosed with triple negative breast cancer—who may still benefit from Avastin.

Learn more.

Medianet BCS
Lockerdome BCS – desktop
The Breast Cancer Site is a place where supporters and survivors come together to help fight breast cancer. In addition to sharing personal stories of hope, shopping for the cause, and signing petitions, visitors can take just a moment each day to click on a pink button to provide free mammograms for women in need. Visit The Breast Cancer Site and click today - it's free!